A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...

InterVenn Biosciences, a life sciences company unlocking the value of glycoproteomics for the development of transformational healthcare solutions, and Aranscia, a global provider of award-winning ...

Data presented during ICCBH 2026 showed that improvements in tibial-femoral angle (TFA), a measure of lower extremity alignment, continued ...

A new study reveals a shocking jump in “biological age” among Gen-X, Millennials, and Gen-Z—and it might explain the rise in early-onset cancers.

Our genetic heritage is not a blueprint or an algorithm, as many biologists have imagined, but something else entirely.

The concept of biological age, distinct from chronological age, is gaining public traction, though often misinterpreted.

A risk model that combines a mammographic artificial intelligence (AI) risk score with polygenic and clinical risk scores ...

Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the ...

Cancer is one of the leading causes of death and disability, affecting millions of working-age adults and their families each ...

For a child diagnosed with neuroblastoma—the most common infant cancer, occurring when early nerve cells grow out of ...

NetraMark Holdings Inc. (the "Company" or "NetraMark") , an artificial intelligence (AI) company that is transforming ...

A quantum-inspired AI approach can analyze millions of molecular features from small datasets, improving predictions, ...